176 related articles for article (PubMed ID: 38589801)
1. Clinical outcomes of liver transplantation in human immunodeficiency virus/hepatitis B virus coinfected patients in China.
Tang J; Weng R; Fang T; Zhang K; Yan X; Jin X; Xie L; Zhao D
BMC Infect Dis; 2024 Apr; 24(1):383. PubMed ID: 38589801
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus.
Tang JX; Zhang KJ; Fang TS; Weng RH; Liang ZM; Yan X; Jin X; Xie LJ; Zeng XC; Zhao D
World J Gastroenterol; 2023 Mar; 29(11):1745-1756. PubMed ID: 37077518
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
[TBL] [Abstract][Full Text] [Related]
5. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
[TBL] [Abstract][Full Text] [Related]
6. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
[TBL] [Abstract][Full Text] [Related]
8. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
Coffin CS; Stock PG; Dove LM; Berg CL; Nissen NN; Curry MP; Ragni M; Regenstein FG; Sherman KE; Roland ME; Terrault NA
Am J Transplant; 2010 May; 10(5):1268-75. PubMed ID: 20346065
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience.
Vernadakis S; Sotiropoulos GC; Brokalaki EI; Esser S; Kaiser GM; Cicinnati VR; Beckebaum S; Paul A; Mathé Z
Eur J Med Res; 2011 Aug; 16(8):342-8. PubMed ID: 21813377
[TBL] [Abstract][Full Text] [Related]
10. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
[TBL] [Abstract][Full Text] [Related]
11. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort.
Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
Clin Infect Dis; 2022 Mar; 74(6):1012-1021. PubMed ID: 34197574
[TBL] [Abstract][Full Text] [Related]
12. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
[TBL] [Abstract][Full Text] [Related]
15. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression.
Huang AJ; Núñez M
J Int Assoc Provid AIDS Care; 2015; 14(4):360-8. PubMed ID: 25999329
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
[TBL] [Abstract][Full Text] [Related]
18. Cluster of differentiation 4+ T-cell counts and human immunodeficiency virus-1 viral load in patients coinfected with hepatitis B virus and hepatitis C virus.
Gupta S; Malhotra B; Tiwari JK; Khandelwal PD; Maheshwari RK
J Lab Physicians; 2018; 10(2):162-167. PubMed ID: 29692581
[TBL] [Abstract][Full Text] [Related]
19. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.
Coffin CS; Osiowy C; Myers RP; Gill MJ
J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393
[TBL] [Abstract][Full Text] [Related]
20. Current status of liver transplantation for human immunodeficiency virus-infected patients in mainland China.
Tang JX; Zhao D
World J Gastroenterol; 2024 Apr; 30(14):1958-1962. PubMed ID: 38681123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]